Brief: Pharming Group Q3 Total Revenues Up At $117.6 Mln
22/10/2026 06:12
BRIEF-Pharming Group Q3 Total Revenues Up At $117.6 Mln Oct 22 (Reuters) - Pharming Group N.V. PHAR.AS:
ANNOUNCES THIRD QUARTER 2026 REVENUES ABOVE MARKET EXPECTATIONS
Q3 2026 TOTAL REVENUES INCREASE 21% TO $117.60 MILLION
Q3 2026 TOTAL OPERATING EXPENSES ABOUT $74.60 MILLION
TIGHTENS 2026 TOTAL REVENUE GUIDANCE TO $380 MILLION-$390 MILLION
LOWERS 2026 TOTAL OPERATING EXPENSE GUIDANCE TO $310 MILLION-$315 MILLION
Source text: ID:nGNX90PLGC
Further company coverage: PHAR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))